Skip to content

MOERMAN ANN

Active
Private limited companyfounded 2008active for 17 yearsBayauxlaan 35, 8300 Knokke-Heist, BelgiumKBO/BCE: BE 0808.468.175
Summary

MOERMAN ANN has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €619,029 and a net result of €81,673. Equity is growing by about 21% per year across the filed financial years. Its solvency ranks better than 86% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
MOERMAN ANNActiveChecked score 97/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €640,000turnover 2025, estimated
Staff
0.1 FTE
Equity
€619,029
Profit
€81,673
Turnover estimated from the gross margin
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 93 days early1 of 2 deeds summarised
Why 97lowers riskLiquidity: current ratio 3.85, cash €190,281Equity €619,029 (75.6% of total assets)Figures for financial year 2025 (filed 01-05-2026)Founded in 2008Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 73% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 75.6% of total assets
Liquidity 70+10
short-term debt 23.7% · cash 23.2%
Profitability 81-2
return on assets 10.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,268 companies, NACE 47, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €60,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.85, compared with 4.24 in 2024, above the usual 1.5; short-term debt: 23.7% and cash: 23.2% of total assets), and 24.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 92% on solvency, 77% on liquidity, 73% on profitability and 51% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 3.85, cash €190,281
NBB · annual accounts
lowers risk · Equity €619,029 (75.6% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 01-05-2026)
NBB · annual accounts
lowers risk · Founded in 2008
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-04-2026, 93 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
93 days early
2024
6 days late
2023
6 days early
2022
7 days early
2021
3 days early
2020
1 day early
2019
74 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Positive: Among the best 14% on solvencysector median 36.6% · 12,737 companies 75.6% View
  • Positive: 8 profitable years in a rowprofit 2025: €81,673 8 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€819,356
Profit
€81,673
Solvency
75.6%
Total assets▲ 8.4%
Net result
20182025
Go to Financials

Timeline

Events
22
Since
2010
Next accounts
by 31-07-2027
  1. 24-04-2024Reappointment: MOERMAN Ann Gerarda Catherina (statutory director)
  2. 31-12-2023Highest result from 2018 to 2025
  3. 31-12-2023Equity above €500,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
16-12-2008
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
18
Who signs
Each director alone
Annual meeting
First Wednesday of June at 19:00
Go to Articles of association

Key facts about MOERMAN ANN

What is the company number of MOERMAN ANN?
0808.468.175. In Belgium the VAT number is the company number with BE in front: BE 0808.468.175.
Where is MOERMAN ANN based?
The registered office is at Bayauxlaan 35, 8300 Knokke-Heist.Company details
What does MOERMAN ANN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of MOERMAN ANN?
Private limited company (BV).
When was MOERMAN ANN founded?
On 16-12-2008.
Is MOERMAN ANN still active?
Yes, MOERMAN ANN is an active enterprise in the KBO register.
How many employees does MOERMAN ANN have?
On average 0.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of MOERMAN ANN?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is MOERMAN ANN profitable?
In financial year 2025, MOERMAN ANN made a profit of €81,673.
Where can I find the annual accounts of MOERMAN ANN?
MOERMAN ANN filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MOERMAN ANN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to MOERMAN ANN

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure